DinoSAVR struck by the TAVR asteroids
ABSTRACT Over the last decade, transcatheter aortic valve replacement (TAVR) has become the preferred treatment for patients with severe aortic stenosis at increased risk for surgery. Consequently, this new technology has been recently tested in low-risk subjects. The PARTNER 3 trial randomized 1000...
Main Authors: | Giuseppe Tarantini, Luca Nai Fovino |
---|---|
Format: | Article |
Language: | English |
Published: |
Permanyer
2019-05-01
|
Series: | REC: Interventional Cardiology (English Ed.) |
Subjects: | |
Online Access: | https://recintervcardiol.org/en/index.php?option=com_content&view=article&id=126 |
Similar Items
-
DinoSAVR noqueado por los asteroides TAVI
by: Giuseppe Tarantini, et al.
Published: (2019-05-01) -
Challenging Anatomies for TAVR—Bicuspid and Beyond
by: Mohammed Saad, et al.
Published: (2021-04-01) -
Will Transcatheter Aortic Valve Replacement (TAVR) be the Primary Therapy for Aortic Stenosis?
by: Jose F. Condado, MD, MS, et al.
Published: (2016-05-01) -
DURABILITY OF BIOLOGICAL PROSTHESES USED FOR MANAGEMENT OF DEGENERATIVE AORTIC STENOSIS – TAVR vs. SAVR
by: Veselin Valkov, et al.
Published: (2018-06-01) -
Comparison of multicenter registries and randomized control trials for transcatheter aortic valve replacement (TAVR)
by: Shikhar Agarwal, et al.
Published: (2013-07-01)